Neuroprotective role of fibroblast growth factor-2 in experimental autoimmune encephalomyelitis

Immunology

Volumn 133, Issue 3, 2011, Pages 370-378

  Rottlaender, Andrea ^a   Villwock, Hannah ^a   Addicks, Klaus ^a   Kuerten, Stefanie ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Demyelination; Experimental autoimmune encephalomyelitis; Fibroblast growth factor 2; Multiple sclerosis; Neuroprotection; Remyelination

Indexed keywords

CD8 ANTIGEN; CYTOKINE; FIBROBLAST GROWTH FACTOR 2; GAMMA INTERFERON; INTERLEUKIN 17; MYELIN; MYELIN OLIGODENDROCYTE GLYCOPROTEIN;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTICLE; CD8+ T LYMPHOCYTE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; FEMALE; IMMUNE RESPONSE; IMMUNIZATION; LYMPHOCYTIC INFILTRATION; MACROPHAGE; MICROGLIA; MOUSE; MULTIPLE SCLEROSIS; NERVE FIBER; NERVE FIBER DEGENERATION; NERVOUS SYSTEM INFLAMMATION; NEUROPROTECTION; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; REMYELINIZATION;

ANIMALS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; FIBROBLAST GROWTH FACTOR 2; MICE; MICE, KNOCKOUT; NEUROPROTECTIVE AGENTS;

EID: 79957807792     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2011.03450.x     Document Type: Article

References (40)

1. Coles AJ, Wing MG, Molyneux P et al. Monoclonal antibody treatment exposes three mechanisms underlying the clinical course of multiple sclerosis. Ann Neurol 1999; 46:296-304.
2. Gospodarowicz D, Moran JS. Mitogenic effect of fibroblast growth factor on early passage cultures of human and murine fibroblasts. J Cell Biol 1975; 66:451-7.
3. Basilico C, Moscatelli D. The FGF family of growth factors and oncogenes. Adv Cancer Res 1992; 59:115-65.
4. Palmer TD, Ray J, Gage FH. FGF-2-responsive neuronal progenitors reside in proliferative and quiescent regions of the adult rodent brain. Mol Cell Neurosci 1995; 6:474-86.
5. Okabe S, Forsberg-Nilsson K, Spiro AC, Segal M, McKay RD. Development of neuronal precursor cells and functional postmitotic neurons from embryonic stem cells in vitro. Mech Dev 1996; 59:89-102.
6. Vicario-Abejón C, Johe KK, Hazel TG, Collazo D, McKay RD. Functions of basic fibroblast growth factor and neurotrophins in the differentiation of hippocampal neurons. Neuron 1995; 5:105-14.
7. Walicke PA, Baird A. Neurotrophic effects of basic and acidic fibroblast growth factors are not mediated through glial cells. Dev Brain Res 1998; 40:71-9.
8. Abe K, Takayanagi M, Saito H. A comparison of neurotrophic effects of epidermal growth factor and basic fibroblast growth factor in primary cultured neurons from various regions of fetal rat brain. Jpn J Pharmacol 1990; 54:45-51.
9. Zechel S, Werner S, Unsicker K, von Bohlen und Halbach O. Expression and functions of fibroblast growth factor 2 (FGF-2) in hippocampal formation. Neuroscientist 2010; 16:357-73.
10. Ruffini F, Furlan R, Poliani PL et al. Fibroblast growth factor-II gene therapy reverts the clinical course and the pathological signs of chronic experimental autoimmune encephalomyelitis in C57BL/6 mice. Gene Ther 2001; 8:1207-13.
11. Messersmith DJ, Murtie JC, Le TQ, Frost EE, Armstrong RC. Fibroblast growth factor-2 (FGF-2) and FGF receptor expression in an experimental demyelinating disease with extensive remyelination. J Neurosci Res 2000; 62:241-56.
12. Goddard DR, Berry M, Kirvell SL, Butt AM. Fibroblast growth factor-2 inhibits myelin production by oligodendrocytes in vivo. Mol Cell Neurosci 2001; 18:557-69.
13. Butt AM, Dinsdale J. Opposing actions of fibroblast growth factor-2 on early and late oligodendrocyte lineage cells in vivo. J Neuroimmunol 2005; 166:75-87.
14. Armstrong RC, Le TQ, Flint NC, Vana AC, Zhou YX. Endogenous cell repair of chronic demyelination. J Neuropathol Exp Neurol 2006; 65:245-56.
15. Sarchielli P, Di Filippo M, Ercolani MV et al. Fibroblast growth factor-2 levels are elevated in the cerebrospinal fluid of multiple sclerosis patients. Neurosci Lett 2008; 435:223-8.
16. Zhou M, Sutliff RL, Paul RJ et al. Fibroblast growth factor 2 control of vascular tone. Nat Med 1998; 4:201-7.
17. Kuerten S, Rodi M, Javeri S, Gruppe TL, Tary-Lehmann M, Lehmann PV, Addicks K. Delineating the impact of neuroantigen vs genetic diversity on MP4-induced EAE of C57BL/6 and B6.129 mice. APMIS 2009; 117:923-35.
18. Guy J, Ellis EA, Hope GM, Emerson S. Maintenance of myelinated fibre g ratio in acute experimental allergic encephalomyelitis. Brain 1991; 114:281-94.
19. Rushton WAH. A theory of the effects of fibre size in medullated nerve. J Physiol 1951; 115:101-22.
20. Bishop GH, Clare MH, Landau WM. The relation of axon sheath thickness to fibre size in the central nervous system of vertebrates. Int J Neurosci 1971; 2:69-77.
21. Goldman L, Albus JS. Computation of impulse conduction in myelinated fibres: theoretical basis of the velocity-diameter relation. Biophys J 1968; 8:596-607.
22. Recks M, Bader J, Kaiser CC, Schroeter M, Fink GR, Addicks K, Kuerten S. Axonal damage and its importance for the concept of neurodegeneration in multiple sclerosis. Fortschr Neurol Psychiatr 2011; 79:161-70.
23. Sospedra M, Martin R. Immunology of multiple sclerosis. Annu Rev Immunol 2005; 23:683-747.
24. Javeri S, Rodi M, Tary-Lehmann M, Lehmann PV, Addicks K, Kuerten S. Involvement of brain-derived neurotrophic factor (BDNF) in MP4-induced autoimmune encephalomyelitis. Clin Immunol 2010; 137:181-9.
25. Bitsch A, Schuschardt J, Brunkowski S, Kuhlmann T, Brück W. Acute axonal injury in multiple sclerosis. Correlation with demyelination and inflammation. Brain 2000; 123:1174-83.
26. Rivera-Quiñones C, McGavern D, Schmelzer JD, Hunter SF, Low PA, Rodriguez M. Absence of neurological deficits following extensive demyelination in a class I-deficient murine model of multiple sclerosis. Nat Med 1998; 4:187-93.
27. Howe CL, Adelson JD, Rodriguez M. Absence of perforin expression confers axonal protection despite demyelination. Neurobiol Dis 2007; 25:354-9.
28. Medana I, Martinic MA, Wekerle H, Neumann H. Transection of major histocompatibility complex class I-induced neuritis by cytotoxic T lymphocytes. Am J Pathol 2001; 159:809-15.
29. Takahashi JL, Giuliana F, Power C, Imai Y, Wee Yong V. Interleukin-1β promotes oligodendrocyte death through glutamate excitotoxicity. Ann Neurol 2003; 53:588-95.
30. Hanisch UK, Kettenmann H. Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat Neurosci 2007; 10:1387-94.
31. Olah M, Biber K, Binet J, Boddeke HW. Microglia phenotype diversity. CNS Neurol Disord Drug Targets 2001; 10:108-18.
32. Graber MB. Changing face of microglia. Science 2010; 330:783-8.
33. Perry VH, Nicoll JA, Holmes C. Microglia in neurodegenerative disease. Nat Rev Neurol 2010; 6:193-201.
34. Almolda B, Gonzalez B, Castellano B. Antigen presentation in EAE: role of microglia, macrophages and dendritic cells. Front Biosci 2011; 16:1157-71.
35. de Haas AD, Boddeke HW, Biber K. Region-specific expression of immunoregulatory proteins on microglia in the healthy CNS. Glia 2008; 56:888-94.
36. Becher B, Durell BG, Miga AV, Hickey WF, Noelle RJ. The clinical course of experimental autoimmune encephalomyelitis and inflammation is controlled by the expression of CD40 within the central nervous system. J Exp Med 2001; 193:967-74.
37. Miller SD, Vanderlugt CL, Lenschow DJ, Pope JG, Karandikar NJ, Dal Canto MC, Bluestone JA. Blockade of CD28/B7-1 interaction prevents epitope spreading and clinical relapses of murine EAE. Immunity 1995; 3:739-45.
38. Zehntner SP, Brisebois M, Tran E, Owens T, Fournier S. Constitutive expression of a costimulatory ligand on antigen-presenting cells in the nervous system drives demyelinating disease. FASEB J 2003; 17:1910-2.
39. Mosser DM, Edwards JP. Exploring the full spectrum of macrophage activation. Nat Rev Immunol 2008; 8:958-69.
40. Jones M, Tussey L, Athanasou N, DG. Heparan sulfate proteoglycan isoforms of the CD44 hyaluronan receptor induced in human inflammatory macrophages can function as paracrine regulators of fibroblast growth factor action. J Biol Chem 2000; 275:7964-74.